Palmoplantar keratoderma Nagashima type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Detection of SERPINB7 mutation can distinguish Nagashima-type palmoplantar keratoderma from other keratodermas with palmoplantar lesions.
|
28211129 |
2017 |
Palmoplantar keratoderma Nagashima type
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.
|
24207119 |
2013 |
Palmoplantar keratoderma Nagashima type
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.
|
24207119 |
2013 |
Palmoplantar keratoderma Nagashima type
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Palmoplantar keratoderma Nagashima type
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Keratoderma, Palmoplantar
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation.
|
31706940 |
2019 |
Keratoderma, Palmoplantar
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Almost all NPPK patients carry the founder nonsense mutation c.796C>T (p.Arg266Ter) in the last exon of SERPINB7.
|
29106929 |
2018 |
Keratoderma, Palmoplantar
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.
|
27666198 |
2016 |
Keratoderma, Palmoplantar
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Highly prevalent SERPINB7 founder mutation causes pseudodominant inheritance pattern in Nagashima-type palmoplantar keratosis.
|
24773080 |
2014 |
Keratoderma, Palmoplantar
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Genetic studies suggest that NPPK is the most common palmoplantar keratosis in Japan, and probably Asia, but one that is extremely rare in Western countries.In this issue, Yin et al. report a founder effect of a SERPINB7 mutation in Chinese populations.
|
25029323 |
2014 |
Keratoderma, Palmoplantar
|
0.450 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Keratoderma, Palmoplantar
|
0.450 |
Biomarker
|
disease |
HPO |
|
|
|
Nephritis
|
0.200 |
Biomarker
|
disease |
RGD |
In order to investigate megsin protein expression in anti-Thy1 nephritis rats, we raised antibody against rat megsin-specific synthetic peptide, with which immunohistochemical studies were performed.
|
11473647 |
2001 |
Asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Shared genetics of asthma and mental health disorders: a large-scale genome-wide cross-trait analysis.
|
31619474 |
2019 |
Asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
|
30929738 |
2019 |
Asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
|
31036433 |
2019 |
Childhood asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.
|
30929738 |
2019 |
Childhood asthma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
|
31036433 |
2019 |
Hyperhidrosis disorder
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acanthosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Maceration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Macerated skin (finding)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperhidrosis Palmaris Et Plantaris
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypergranulosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Orthokeratotic hyperkeratosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|